Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
0
Number of overlapping holdings
0.0%
% of MEDX's 30 holdings also in XDNA
nan%
% of XDNA's 3 holdings also in MEDX
Overlap by Weight
Sector Drift (MEDX minus XDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in XDNA |
Overlap | |
|---|---|---|---|---|
Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to XDNA
 |
ELI LILLY & CO | 17.0% |
|
ABBVIE INC | 7.9% |
 |
NOVARTIS AG-ADR | 6.1% |
|
AMGEN INC | 5.9% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.8% |
|
BRISTOL-MYERS SQUIBB CO | 4.7% |
|
REGENERON PHARMACEUTICALS | 4.5% |
|
JOHNSON & JOHNSON | 4.5% |
|
MERCK & CO. INC. | 4.2% |
|
ALNYLAM PHARMACEUTICALS INC | 4.0% |
MEDX Underweight Relative to XDNA
 |
MURAL ONCOLOGY PLC | 0.0% |
|
PACIFIC BIOSCIENCES OF CALIF | 0.1% |
|
BLUEBIRD BIO INC | 0.1% |
|
VIATRIS, INC. | 0.2% |
|
ALLOGENE THERAPEUTICS, INC. | 0.3% |
|
GE HEALTHCARE TECHNOLOGIES INC. | 0.4% |
|
2SEVENTY BIO, INC. | 0.4% |
|
LANTERN PHARMA, INC. | 0.6% |
|
EDITAS MEDICINE, INC. | 0.6% |
|
VANDA PHARMACEUTICALS INC | 0.7% |